Vivanza Biosciences
2.10
+0.10(+5.00%)
Market Cap₹8.40 Cr
PE Ratio-50.00
IndustryHealthcare
Company Performance:
1D+5.00%
1M+15.38%
6M+2.44%
1Y-9.87%
5Y-80.08%
View Company Insightsright
More news about Vivanza Biosciences
17Mar 26
Vivanza Biosciences Director Hemant Parikh Resigns Due to Personal Reasons
Vivanza Biosciences Limited formally announced the resignation of Mr. Hemant Amrish Parikh as Non-Executive Director, effective from close of business hours on March 17, 2026. The resignation was attributed to personal reasons with confirmation that no material concerns exist beyond those stated, ensuring full regulatory compliance under SEBI Listing Obligations.
 no imag found
18Dec 25
Vivanza Biosciences Formalizes MOA Amendment for Packaging Business Expansion
Vivanza Biosciences has officially informed BSE about the approved amendment to its Memorandum of Association for expanding into plastic polymer films and packaging materials manufacturing. The company received overwhelming 99.90% shareholder approval through postal ballot, enabling diversification from biosciences into comprehensive packaging solutions including PE/PP bags, paper bags, and flexible packaging materials for various industries.
 no imag found
11Nov 25
Vivanza Biosciences Reports Q2 Results, Appoints New Company Secretary, Plans Business Expansion
Vivanza Biosciences Limited announced key developments in its board meeting on November 11, 2025. The company reported Q2 FY2026 revenue of Rs. 373.18 lacs and profit before tax of Rs. 48.06 lacs. CS Chaitra Arora was appointed as the new Company Secretary and Compliance Officer, replacing CS Siddhi Shah who resigned. The board proposed expanding the business to include manufacturing of plastic polymer films, plastic bags, paper bags, and flexible packaging materials. A postal ballot process has been initiated for shareholder approval of the proposed changes to the Memorandum of Association.
 no imag found
28Oct 25
Vivanza Biosciences Promoter Reduces Stake by 3.07% Through Market Transaction
Parth H. Parikh, a promoter of Vivanza Biosciences Limited, sold 12,28,781 shares (3.07% of total share capital) in an on-market transaction on October 29, 2024. This reduced his shareholding from 31.58% to 28.50%. The company's total equity share capital stands at 40,000,000 shares with a face value of Rs. 1 per share.
 no imag found
Vivanza Biosciences
2.10
+0.10
(+5.00%)
1 Year Returns:-9.87%
Industry Peers
Sun Pharmaceutical
1,620.40
(-3.55%)
Divis Laboratories
6,361.50
(-0.27%)
Torrent Pharmaceuticals
4,117.20
(-0.72%)
Dr Reddys Laboratories
1,317.10
(-1.04%)
Lupin
2,296.10
(-1.93%)
Cipla
1,295.00
(-0.83%)
Mankind Pharma
2,267.40
(-1.11%)
Zydus Life Science
927.40
(-2.00%)
Aurobindo Pharma
1,413.80
(-1.50%)
Glenmark Pharmaceuticals
2,299.50
(-1.52%)